Search clinical trials for: Carbapenem-resistant Enterobacteriaceae

Total 377 results

Jiangsu Province Centers for Disease Control and...
Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.

Completed

A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

Staphylococcus Aureus Infection

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Maastricht University Medical Center; Erasmus Medical Center; ZonMw: The Netherlands... and other collaborators

Completed

Carriage Of Multiresistant Bacteria After Travel (COMBAT)

Enterobacteriaceae, Infection

Netherlands
CHU de Reims

Completed

Qnr Genes in Enterobacteriaceae

Enterobacteriaceae Infection

France
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
CHU de Reims

Unknown

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region (CARBAFREST)

Infection With Beta-lactam Resistance in Enterobacteriaceae

France
Xiamen Innovax Biotech Co., Ltd
Xiamen University; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

Hepatitis E

China
GlycoVaxyn AG

Completed

Vaccine Against Escherichia Coli Infection

E.Coli Infections

Switzerland
Corporacion Parc Tauli

Unknown

Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital. (EME)

Pregnancy | Multi-resistant Enterobacteriaceae Colonisation | Nosocomial Outbreaks

Spain
University of Cologne
University Hospital Tuebingen; Universitätsklinikum Hamburg-Eppendorf; University...

Unknown

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards (CONTAIN)

Hematological Disease | Oncology [See Also, Affected System] | Infection Due to ESBL Escherichia Coli
National Institute of Allergy and Infectious Diseases...

Completed

Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers

Plague

United States
LimmaTech Biologics AG
Wellcome Trust; Naval Medical Research Center

Completed

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Shigellosis

United States
University of Pittsburgh

Completed

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

Infection | Proteus Infections | Klebsiella Infections | E Coli Infections

United States
University of Pittsburgh

Completed

Antibiotic Resistant Community-Acquired E. Coli

E Coli Infection

United States
Maimónides Biomedical Research Institute of Córdoba

Completed

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

Patients Colonized by Klebsiella Pneumoniae.
Jiangsu Province Centers for Disease Control and...
Lanzhou Institute of Biological Products Co., Ltd

Completed

Immunogenicity and Safety of Subunit Plague Vaccine

Plague

China
U.S. Army Medical Research and Development Command
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children

Diarrhea
Mahidol University

Unknown

Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli (SETAP)

Acute Pyelonephritis | Infection Due to Escherichia Coli

Thailand
CSA Medical, Inc.

Terminated

Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") (ICEtheBAD)

Lung Diseases, Obstructive | Wegener's Granulomatosis | Sarcoidosis | Recurrent Respiratory Papillomatosis | Rhinoscleroma

United States
Fundación Pública Andaluza Progreso y Salud

Completed

Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae (BACTERIEMIA)

Bacteremia by Enterobacteriaceae

Spain
Yonsei University

Completed

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Shigella Sonnei Infection
Pherecydes Pharma

Unknown

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (PHAGOBURN)

Wound Infection

Belgium, France, Switzerland
American University of Beirut Medical Center
Merck Sharp & Dohme LLC

Completed

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Escherichia Coli Infections | Klebsiella Pneumonia

Lebanon
U.S. Army Medical Research and Development Command

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
Mansoura University

Completed

Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis? (EPEC)

Colorectal Carcinoma | Enteropathogenic Escherichia Coli .

Egypt
University Hospital, Clermont-Ferrand
University Hospital, Estaing; Hopital Gabriel Montpied

Unknown

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)

Antibiotic Resistance | Extended-spectrum Betalactamase | Enterobacteriaceae | Escherichia Coli

France
University of Pittsburgh

Withdrawn

Ampicillin-sulbactam Resistant E.Coli at UPMC

Positive E Coli Infections

United States
Johann DD Pitout
Merck Sharp & Dohme LLC

Completed

International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli

Infection Due to Resistant Bacteria

Canada
Sheba Medical Center

Unknown

Typhoid Fever: Combined vs. Single Antibiotic Therapy

Typhoid Fever

Nepal
JESUS RODRIGUEZ BAÑO

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study (INCREMENT)

Clinically Significant Bacteremia

Spain
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Bacterial Infections | Typhoid Fever | Salmonella Infections

Japan
National Institute of Allergy and Infectious Diseases...

Completed

CVD 909 Vi Prime Boost Study

Typhoid Fever

United States
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

Typhoid Fever

Pakistan, India
Helsinki University Central Hospital

Unknown

Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines (Ty21a-ASC)

Healthy

Finland
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Typhoid Fever

Philippines
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
Novartis
Novartis Vaccines

Completed

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Japanese Encephalitis | Rabies | Yellow Fever | Meningococcal Disease | Typhoid | Meningococcal Meningitis

Czech Republic, Germany
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of ETEC Vaccine

Gastroenteritis Escherichia Coli

United States
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Typhoid Fever

Belgium
Alexion Pharmaceuticals

Completed

Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS) (STEC-HUS)

Shiga-like Toxin-producing Escherichia Coli

Germany
Belpharma s.a.

Withdrawn

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae (TEA)

Urinary Tract Infection

United Kingdom
Soroka University Medical Center

Unknown

SDD for Eradicating CRKP Carriage

Carriers of Carbapenem-resistant Klebsiella Pneumonia

Israel
University Hospital, Bordeaux

Completed

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 (SHU O104 CUB)

Escherichia Coli Infections | Hemolytic-uremic Syndrome

France
National Taiwan University Hospital

Completed

Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features

Necrotizing Fasciitis

Taiwan
National Taiwan University Hospital

Completed

The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan

Enterobacteriaceae Infections

Taiwan
Centers for Disease Control and Prevention
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda

Unknown

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

Plague

Uganda
University Hospital, Geneva

Completed

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Enterobacteriaceae Infections

Switzerland
Eunice Kennedy Shriver National Institute of Child...

Completed

Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants

Typhoid Fever

Vietnam
Eunice Kennedy Shriver National Institute of Child...
The Chaim Sheba Medical Center; Schneider Children's Medical Center, Israel

Completed

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

Shigellosis

Israel
China Academy of Chinese Medical Sciences

Unknown

A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals

Bronchitis | Infantile Diarrhea | Viral Pneumonia | Bacillary Dysentery | Virus Hepatitis

Search clinical trials for: Carbapenem-resistant Enterobacteriaceae

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations